Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2021 - 2026)

Biolife Solutions (BLFS) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $198000.0 in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $198000.0, up 52.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $198000.0 (up 52.31% YoY), and the FY2025 annual result was $189000.0, up 52.42% from the prior year.
• Non-Current Deferred Tax Liability advanced to $198000.0 in Q1 2026 per BLFS's latest filing, from $189000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $11.2 million in Q4 2022 and troughed at $100000.0 in Q3 2024.
• A 5-year average of $1.2 million and a median of $193000.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability soared 104.7% in 2022, then tumbled 98.99% in 2023.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $11.2 million in 2022, then plunged by 98.99% to $114000.0 in 2023, then grew by 8.77% to $124000.0 in 2024, then soared by 52.42% to $189000.0 in 2025, then increased by 4.76% to $198000.0 in 2026.
• Business Quant data shows BLFS's Non-Current Deferred Tax Liability at $198000.0 in Q1 2026, $189000.0 in Q4 2025, and $189000.0 in Q3 2025.